Cloning, Expression, and Characterization of Mouse Tissue Factor Pathway Inhibitor (TFPI)
暂无分享,去创建一个
J. Oliver | D. Monroe | H. Roberts | J. Chang | D. Liles | Jen-Yea Chang
[1] D. Stafford,et al. The roles of factor VII's structural domains in tissue factor binding. , 1995, Biochemistry.
[2] T. Miyata,et al. Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor: a segment, Gly212-Phe243, of the third Kunitz domain is a heparin-binding site. , 1995, Biochemistry.
[3] G. Broze,et al. Complementary DNA sequencing of canine tissue factor pathway inhibitor reveals a unique nanomeric repetitive sequence between the second and third Kunitz domains. , 1994, Biochemical Journal.
[4] W. Kisiel,et al. Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[5] T. Abumiya,et al. Amino acid sequence and inhibitory activity of rhesus monkey tissue factor pathway inhibitor (TFPI): comparison with human TFPI. , 1994, Journal of biochemistry.
[6] M. King,et al. A rapid and efficient, nonradioactive method for screening recombinant DNA libraries. , 1994, BioTechniques.
[7] R. Wesselschmidt,et al. Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin. , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[8] M. Emi,et al. cDNA cloning and expression of rat tissue factor pathway inhibitor (TFPI). , 1992, Journal of biochemistry.
[9] R. Wesselschmidt,et al. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa. , 1992, Blood.
[10] G. Broze,et al. The lipoprotein-associated coagulation inhibitor. , 1991, Progress in hemostasis and thrombosis.
[11] R. Wesselschmidt,et al. cDNA sequence of rabbit lipoprotein-associated coagulation inhibitor. , 1990, Nucleic acids research.
[12] K. Norris,et al. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions. , 1990, The Journal of biological chemistry.
[13] D. Monroe,et al. Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domain. , 1990, The Journal of biological chemistry.
[14] Susan G. Brown,et al. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor , 1989, Nature.
[15] J. Miletich,et al. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. , 1988, The Journal of biological chemistry.
[16] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[17] F. Sanger,et al. DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[18] R. Lundblad. A rapid method for the purification of bovine thrombin and the inhibition of the purified enzyme wtih phenylmethylsulfonyl fluoride. , 1971, Biochemistry.